Comparison of MGH-1 and TuMark antibody detection in transitional cell carcinoma.
case_control · Level III
Where this comes from
- Record sourced from PubMed, PMID 8411450.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Two monoclonal antibodies, TuMark-BTA and MGH-1, were evaluated in patients with benign pathology, history of transitional cell carcinoma with no active disease and active transitional cell carcinoma. Both antibodies were accurate in predicting carcinoma in approximately two-thirds of patients. TuMark showed a 74% sensitivity and 50% specificity, while MGH-1 was more sensitive (86%) and less specific (38%). Positive predictive values for TuMark and MGH-1 were 79% and 78%, respectively.
Medical subject headings
- Antibodies, Monoclonal
- Antigens, Neoplasm
- Carcinoma, Transitional Cell
- Urinary Bladder Diseases
- Urinary Bladder Neoplasms